Donath, Carolin
Luttenberger, Katharina
Geiß, Christa
Albert, Patricia
Fraunberger, Britta
Funding for this research was provided by:
Friedrich-Alexander-Universität Erlangen-Nürnberg
Article History
Received: 23 November 2021
Accepted: 17 March 2022
First Online: 21 April 2022
Declarations
:
: The manuscript is based on routine data—which means that no extra data besides those necessary for care were collected for study reasons. The patients were informed about the treatment and the kind of data collection that would accompany their therapy. They gave written informed consent to be treated and to have their data collected. The data were anonymized, and the person who carried out the data analysis did not see any person-related information in the data and also did not see any patients in person so that it would be impossible to form a connection between sensitive data and real people. The data were treated according to the German and Bavarian legislative rules for data protection. Routine data collection accompanies therapeutic action at the University Clinic Erlangen as a matter of quality assurance. The data acquired at the Interdisciplinary Pain Center in the context of multimodal pain therapy and used in this study were approved by the review board of the Clinic for Anesthesiology of the University Hospital Erlangen.
: Not applicable.
: PA received honoraria for presentations and support to attend meetings by Grünenthal GmbH in 2019. BF received honoraria for presentations by Lilly and and Teva and support for travelling to present data by Lilly. CD, KL and CG declare that they have no potentially competing interests.